Profiles

Keywords
Last Name
Institution

Erik Schadde

Concepts (257)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
38
2021
65
12.280
Why?
Liver Neoplasms
29
2021
117
10.180
Why?
Portal Vein
28
2021
47
9.540
Why?
Liver
19
2021
214
6.510
Why?
Liver Regeneration
16
2020
27
5.570
Why?
Colorectal Neoplasms
13
2021
125
3.890
Why?
Ligation
21
2020
37
2.680
Why?
Embolization, Therapeutic
6
2021
80
2.530
Why?
Laparoscopy
6
2021
190
1.910
Why?
Hepatic Stellate Cells
2
2020
11
1.520
Why?
Liver Diseases
2
2018
40
1.320
Why?
Postoperative Complications
12
2021
1083
1.230
Why?
Cause of Death
3
2017
78
1.230
Why?
Registries
9
2019
214
1.180
Why?
Liver Failure
4
2019
14
1.100
Why?
Carcinoma, Hepatocellular
3
2021
41
1.040
Why?
Humans
52
2021
31481
0.950
Why?
Treatment Outcome
20
2021
3910
0.940
Why?
Hypertrophy
4
2017
20
0.880
Why?
Organ Size
9
2019
122
0.870
Why?
Sarcopenia
1
2021
34
0.840
Why?
Vascular Endothelial Growth Factor A
1
2020
70
0.780
Why?
Retrospective Studies
16
2021
3591
0.770
Why?
Neovascularization, Pathologic
1
2020
68
0.770
Why?
Male
36
2021
17583
0.750
Why?
Kidney Transplantation
5
2021
141
0.750
Why?
Organ Sparing Treatments
1
2019
11
0.740
Why?
Hepatomegaly
1
2018
6
0.730
Why?
Reperfusion Injury
1
2018
9
0.730
Why?
Neuroendocrine Tumors
5
2019
48
0.720
Why?
Publication Bias
1
2018
8
0.710
Why?
Bibliometrics
1
2018
22
0.690
Why?
Antioxidants
1
2018
70
0.690
Why?
Reactive Oxygen Species
1
2018
133
0.680
Why?
Oxidative Stress
1
2018
140
0.680
Why?
Practice Guidelines as Topic
1
2020
389
0.660
Why?
Neovascularization, Physiologic
1
2017
29
0.660
Why?
Middle Aged
26
2019
11209
0.650
Why?
Female
31
2021
18253
0.620
Why?
Therapies, Investigational
1
2016
6
0.610
Why?
Length of Stay
5
2021
377
0.600
Why?
Aged
20
2019
10295
0.560
Why?
Graft Rejection
4
2008
84
0.520
Why?
Catheter Ablation
1
2015
76
0.520
Why?
Liver Transplantation
3
2015
114
0.490
Why?
Animals
8
2021
5312
0.480
Why?
Blood Loss, Surgical
3
2019
71
0.480
Why?
Prognosis
8
2020
1028
0.450
Why?
Risk Factors
10
2019
2664
0.450
Why?
Time Factors
9
2019
1902
0.440
Why?
Feasibility Studies
4
2016
281
0.430
Why?
Hepatic Veins
3
2020
9
0.430
Why?
Operative Time
4
2019
97
0.410
Why?
Survival Rate
6
2018
465
0.400
Why?
Follow-Up Studies
7
2018
2028
0.380
Why?
Models, Animal
3
2020
149
0.380
Why?
Tissue Donors
2
2021
79
0.380
Why?
Random Allocation
3
2018
164
0.380
Why?
Isoantibodies
2
2006
11
0.370
Why?
Neoplasm Staging
5
2018
481
0.370
Why?
Intestinal Neoplasms
2
2018
13
0.360
Why?
Antibodies, Neoplasm
1
2008
15
0.350
Why?
Pancreatic Neoplasms
3
2019
181
0.350
Why?
Stomach Neoplasms
2
2018
40
0.350
Why?
Pancreas Transplantation
2
2021
16
0.340
Why?
Death
1
2008
45
0.340
Why?
Swine
2
2018
117
0.340
Why?
Rats, Wistar
2
2017
64
0.320
Why?
Vascular Surgical Procedures
2
2019
56
0.320
Why?
Immunosuppressive Agents
1
2008
163
0.320
Why?
Patient Selection
4
2018
264
0.310
Why?
Switzerland
3
2021
9
0.310
Why?
Antibodies, Monoclonal
1
2008
301
0.310
Why?
Adult
15
2019
9779
0.300
Why?
Plasmapheresis
1
2006
17
0.300
Why?
HLA Antigens
1
2006
20
0.300
Why?
Antibody Formation
1
2006
33
0.300
Why?
Rats
2
2020
966
0.290
Why?
Risk Assessment
5
2019
806
0.280
Why?
Philosophy, Medical
1
2004
3
0.280
Why?
Spirituality
1
2004
64
0.260
Why?
Ultrasonography
3
2021
210
0.240
Why?
Tissue and Organ Procurement
3
2012
37
0.230
Why?
Multivariate Analysis
4
2019
390
0.230
Why?
Cell Proliferation
2
2020
232
0.220
Why?
Organ Transplantation
1
2021
43
0.220
Why?
Graft vs Host Disease
1
2021
55
0.220
Why?
Xenograft Model Antitumor Assays
1
2021
31
0.220
Why?
Databases, Factual
3
2019
391
0.220
Why?
Hospitals
1
2021
142
0.210
Why?
Severity of Illness Index
2
2019
1240
0.210
Why?
Biliary Tract Neoplasms
1
2020
4
0.200
Why?
Gene Expression Regulation, Neoplastic
1
2021
136
0.200
Why?
Antineoplastic Agents
2
2021
274
0.200
Why?
Adrenalectomy
1
2019
6
0.200
Why?
Brazil
2
2016
37
0.190
Why?
Adrenal Cortex Neoplasms
1
2019
13
0.190
Why?
Disease Susceptibility
1
2020
80
0.190
Why?
Adrenocortical Carcinoma
1
2019
12
0.190
Why?
Chemotherapy, Adjuvant
1
2019
109
0.190
Why?
Conversion to Open Surgery
1
2019
4
0.190
Why?
Abdominal Neoplasms
1
2019
13
0.180
Why?
Liver Function Tests
4
2017
33
0.180
Why?
Preoperative Period
1
2019
73
0.180
Why?
Gallium Radioisotopes
1
2018
3
0.180
Why?
bcl-2-Associated X Protein
1
2018
13
0.180
Why?
Cytoprotection
1
2018
11
0.180
Why?
Culture Media, Conditioned
1
2018
33
0.180
Why?
Paracrine Communication
1
2018
8
0.180
Why?
Organometallic Compounds
1
2018
23
0.180
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
32
0.180
Why?
Hepatocytes
1
2018
13
0.180
Why?
Hospital Mortality
3
2015
192
0.180
Why?
Anesthesia
1
2018
29
0.180
Why?
Digestive System Surgical Procedures
1
2018
27
0.180
Why?
Pulmonary Embolism
1
2019
57
0.180
Why?
Venous Thrombosis
1
2019
51
0.170
Why?
Venous Thromboembolism
1
2019
53
0.170
Why?
Gastric Bypass
1
2018
56
0.170
Why?
Portal Pressure
1
2017
5
0.170
Why?
Liver Circulation
1
2017
6
0.170
Why?
Cell Line, Tumor
1
2018
290
0.170
Why?
Logistic Models
3
2016
479
0.170
Why?
Survival Analysis
2
2017
379
0.160
Why?
Models, Biological
1
2020
428
0.160
Why?
Hyperplasia
1
2017
26
0.160
Why?
Fatty Liver
1
2017
40
0.160
Why?
Melanoma
1
2017
63
0.160
Why?
Tomography, X-Ray Computed
3
2017
891
0.160
Why?
Apoptosis
1
2018
292
0.160
Why?
Cell Hypoxia
1
2016
17
0.160
Why?
Randomized Controlled Trials as Topic
1
2018
375
0.150
Why?
Cholangiocarcinoma
1
2016
8
0.150
Why?
Bile Duct Neoplasms
1
2016
10
0.150
Why?
Reproducibility of Results
1
2019
886
0.150
Why?
Primary Graft Dysfunction
1
2015
3
0.150
Why?
Adenocarcinoma
1
2017
237
0.150
Why?
Carcinoma, Squamous Cell
1
2017
207
0.150
Why?
Methyl Ethers
1
2015
8
0.150
Why?
Anesthetics, Intravenous
1
2015
11
0.150
Why?
Anesthetics, Inhalation
1
2015
12
0.150
Why?
Propofol
1
2015
18
0.140
Why?
Transplantation Conditioning
1
2015
40
0.140
Why?
Signal Transduction
1
2018
588
0.140
Why?
Obesity
1
2018
338
0.140
Why?
Cohort Studies
3
2017
2014
0.140
Why?
Safety
1
2014
59
0.140
Why?
Disease Models, Animal
1
2018
832
0.140
Why?
Surgeons
1
2016
84
0.140
Why?
Neoplasm Invasiveness
1
2014
104
0.130
Why?
Viscera
1
2013
2
0.130
Why?
Vascular Patency
1
2013
31
0.130
Why?
Renal Artery
1
2013
10
0.130
Why?
Aneurysm
1
2013
20
0.120
Why?
Blood Vessel Prosthesis
1
2013
27
0.120
Why?
Blood Vessel Prosthesis Implantation
1
2013
44
0.120
Why?
Blood Transfusion
1
2012
68
0.120
Why?
Endovascular Procedures
1
2013
79
0.120
Why?
Bilirubin
2
2016
14
0.110
Why?
Resource Allocation
1
2011
5
0.110
Why?
Health Care Rationing
1
2011
8
0.110
Why?
Linear Models
1
2012
276
0.110
Why?
End Stage Liver Disease
1
2011
17
0.110
Why?
Stents
1
2013
155
0.110
Why?
Liver Cirrhosis
2
2012
60
0.100
Why?
Histocompatibility Testing
1
2009
6
0.100
Why?
HLA-C Antigens
1
2009
9
0.100
Why?
Antilymphocyte Serum
1
2008
7
0.090
Why?
Receptors, Interleukin-2
1
2008
11
0.090
Why?
Disease-Free Survival
2
2019
241
0.090
Why?
Minor Histocompatibility Antigens
1
2007
3
0.090
Why?
Blood Vessels
1
2007
19
0.090
Why?
Immunocompromised Host
1
2008
55
0.090
Why?
Graft Survival
1
2008
111
0.080
Why?
Glomerular Filtration Rate
1
2008
77
0.080
Why?
Kidney Failure, Chronic
1
2009
176
0.080
Why?
Heart Transplantation
1
2007
50
0.080
Why?
Cytomegalovirus Infections
1
2008
84
0.080
Why?
Incidence
2
2021
829
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2008
136
0.080
Why?
CD8-Positive T-Lymphocytes
1
2007
179
0.080
Why?
HLA-DP Antigens
1
2006
1
0.080
Why?
Complement C4b
1
2006
3
0.080
Why?
Body Mass Index
2
2018
458
0.070
Why?
Peptide Fragments
1
2006
122
0.070
Why?
Aged, 80 and over
4
2017
5234
0.070
Why?
Religion and Medicine
1
2004
24
0.070
Why?
Prospective Studies
2
2021
1934
0.070
Why?
Hospitals, University
2
2018
46
0.060
Why?
Magnetic Resonance Imaging
2
2021
1273
0.060
Why?
Naphthoquinones
1
2021
6
0.060
Why?
Benzofurans
1
2021
8
0.050
Why?
Aniline Compounds
1
2021
40
0.050
Why?
Transplant Recipients
1
2021
19
0.050
Why?
Pancreas
1
2021
36
0.050
Why?
Cold Ischemia
2
2011
3
0.050
Why?
Sulfonamides
1
2021
64
0.050
Why?
Mice
2
2021
1894
0.050
Why?
Contrast Media
1
2021
144
0.050
Why?
Mitotane
1
2019
3
0.050
Why?
Kidney
1
2021
210
0.050
Why?
Preoperative Care
1
2020
146
0.050
Why?
Argentina
1
2019
1
0.050
Why?
Blood Coagulation Disorders
1
2019
15
0.050
Why?
Digestive System Neoplasms
1
2018
6
0.050
Why?
Postoperative Nausea and Vomiting
1
2018
17
0.050
Why?
Serum Albumin
1
2019
28
0.050
Why?
Thymus Neoplasms
1
2018
14
0.050
Why?
Cytoreduction Surgical Procedures
1
2018
7
0.050
Why?
Europe
1
2019
88
0.050
Why?
Combined Modality Therapy
1
2019
456
0.040
Why?
Neoplasm Metastasis
1
2018
129
0.040
Why?
United States
2
2018
2539
0.040
Why?
Radionuclide Imaging
1
2017
58
0.040
Why?
Gastrointestinal Neoplasms
1
2017
30
0.040
Why?
Salvage Therapy
1
2017
42
0.040
Why?
Postoperative Period
1
2019
295
0.040
Why?
Anticoagulants
1
2019
151
0.040
Why?
Edema
1
2017
40
0.040
Why?
Treatment Failure
1
2017
187
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
405
0.040
Why?
Biopsy, Needle
1
2017
117
0.040
Why?
Italy
1
2016
16
0.040
Why?
Medical Audit
1
2016
8
0.040
Why?
Ovarian Neoplasms
1
2017
82
0.040
Why?
Hospitals, High-Volume
1
2016
10
0.040
Why?
Rabbits
1
2017
326
0.040
Why?
Neoplasm Recurrence, Local
1
2017
236
0.040
Why?
Health Care Surveys
1
2016
77
0.040
Why?
Belgium
1
2015
3
0.040
Why?
Immunohistochemistry
1
2017
494
0.040
Why?
Age Factors
1
2018
943
0.040
Why?
Aspartate Aminotransferases
1
2015
20
0.040
Why?
Sarcoma
1
2017
139
0.030
Why?
Healthcare Disparities
1
2016
82
0.030
Why?
Proportional Hazards Models
1
2016
390
0.030
Why?
Odds Ratio
1
2015
327
0.030
Why?
Predictive Value of Tests
1
2016
637
0.030
Why?
Graft Occlusion, Vascular
1
2013
29
0.030
Why?
Breast Neoplasms
1
2017
442
0.030
Why?
Case-Control Studies
1
2015
687
0.030
Why?
Lung Neoplasms
1
2018
756
0.030
Why?
Waiting Lists
1
2011
18
0.030
Why?
Health Status Indicators
1
2012
82
0.030
Why?
Guidelines as Topic
1
2011
79
0.030
Why?
False Negative Reactions
1
2009
16
0.020
Why?
Immunization
1
2009
50
0.020
Why?
Algorithms
1
2012
412
0.020
Why?
Receptors, CXCR3
1
2007
2
0.020
Why?
Histocompatibility
1
2007
5
0.020
Why?
Mice, Mutant Strains
1
2007
30
0.020
Why?
Child
1
2012
1572
0.020
Why?
Transplantation, Homologous
1
2007
292
0.020
Why?
Wisconsin
1
2006
6
0.020
Why?
Kidney Tubules
1
2006
15
0.020
Why?
Atrophy
1
2006
108
0.020
Why?
Kidney Glomerulus
1
2006
96
0.020
Why?
Schadde's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description